TreeWAS – Variant ID: rs1860374

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
I25.9 Chronic ischaemic heart disease, unspecified	1.000	0.000	0.000
I25 Chronic ischaemic heart disease	1.000	0.000	0.000
I20-I25 Ischaemic heart diseases	0.999	0.001	0.000
I60-I69 Cerebrovascular diseases	0.997	0.003	0.000
Chapter IX Diseases of the circulatory system	0.996	0.004	0.000
I69 Sequelae of cerebrovascular disease	0.995	0.005	0.000
I20 Angina pectoris	0.991	0.009	0.000
I20.9 Angina pectoris, unspecified	0.988	0.012	0.000
I63 Cerebral infarction	0.982	0.018	0.000
I69.3 Sequelae of cerebral infarction	0.972	0.028	0.000
I69.4 Sequelae of stroke, not specified as haemorrhage or infarction	0.965	0.035	0.000
I25.2 Old myocardial infarction	0.945	0.055	0.000
I63.2 Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries	0.935	0.065	0.000
I63.8 Other cerebral infarction	0.929	0.071	0.000
I61 Intracerebral haemorrhage	0.921	0.079	0.000
I25.1 Atherosclerotic heart disease	0.914	0.086	0.000
I10-I15 Hypertensive diseases	0.885	0.115	0.000
I11 Hypertensive heart disease	0.869	0.131	0.000
I69.1 Sequelae of intracerebral haemorrhage	0.865	0.135	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.851	0.149	0.000
I64 Stroke, not specified as haemorrhage or infarction	0.849	0.151	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.848	0.152	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.848	0.152	0.000
I11.9 Hypertensive heart disease without (congestive) heart failure	0.836	0.164	0.000
I63.9 Cerebral infarction, unspecified	0.828	0.172	0.000
I63.0 Cerebral infarction due to thrombosis of precerebral arteries	0.824	0.176	0.000
C92 Myeloid leukaemia	0.821	0.179	0.000
I25.0 Atherosclerotic cardiovascular disease, so described	0.818	0.182	0.000
I25.5 Ischaemic cardiomyopathy	0.816	0.184	0.000
C85.1 B-cell lymphoma, unspecified	0.814	0.186	0.000
I66 Occlusion and stenosis of cerebral arteries, not resulting in cerebral infarction	0.809	0.191	0.000
I61.1 Intracerebral haemorrhage in hemisphere, cortical	0.796	0.204	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.796	0.204	0.000
I26-I28 Pulmonary heart disease and diseases of pulmonary circulation	0.793	0.207	0.000
I24 Other acute ischaemic heart diseases	0.788	0.212	0.000
I61.9 Intracerebral haemorrhage, unspecified	0.784	0.216	0.000
I11.0 Hypertensive heart disease with (congestive) heart failure	0.780	0.219	0.000
C92.0 Acute myeloid leukaemia	0.776	0.224	0.000
I05-I09 Chronic rheumatic heart diseases	0.769	0.231	0.000
I61.5 Intracerebral haemorrhage, intraventricular	0.754	0.246	0.000
I69.2 Sequelae of other nontraumatic intracranial haemorrhage	0.743	0.257	0.000
I61.0 Intracerebral haemorrhage in hemisphere, subcortical	0.743	0.257	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.730	0.270	0.000
I00-I02 Acute rheumatic fever	0.726	0.274	0.000
I27 Other pulmonary heart diseases	0.720	0.280	0.000
I25.6 Silent myocardial ischaemia	0.717	0.283	0.000
C92.4 Acute promyelocytic leukaemia	0.716	0.284	0.000
I68 Cerebrovascular disorders in diseases classified elsewhere	0.714	0.285	0.000
I61.2 Intracerebral haemorrhage in hemisphere, unspecified	0.712	0.288	0.000
I63.6 Cerebral infarction due to cerebral venous thrombosis, nonpyogenic	0.704	0.296	0.000
I63.1 Cerebral infarction due to embolism of precerebral arteries	0.704	0.296	0.000
I20.8 Other forms of angina pectoris	0.703	0.297	0.000
C84.4 Peripheral T-cell lymphoma	0.701	0.299	0.000
I69.0 Sequelae of subarachnoid haemorrhage	0.700	0.300	0.000
C84.5 Other and unspecified T-cell lymphomas	0.695	0.305	0.000
I23 Certain current complications following acute myocardial infarction	0.690	0.310	0.000
I24.0 Coronary thrombosis not resulting in myocardial infarction	0.689	0.311	0.000
I08 Multiple valve diseases	0.685	0.315	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.672	0.328	0.000
I30-I52 Other forms of heart disease	0.670	0.330	0.000
I50.0 Congestive heart failure	0.667	0.333	0.000
I61.8 Other intracerebral haemorrhage	0.666	0.334	0.000
I66.0 Occlusion and stenosis of middle cerebral artery	0.664	0.336	0.000
I20.1 Angina pectoris with documented spasm	0.663	0.337	0.000
I25.3 Aneurysm of heart	0.661	0.338	0.000
I61.6 Intracerebral haemorrhage, multiple localised	0.660	0.339	0.000
I50 Heart failure	0.659	0.341	0.000
H40.1 Primary open-angle glaucoma	0.654	0.346	0.000
H40 Glaucoma	0.648	0.352	0.000
I66.4 Occlusion and stenosis of multiple and bilateral cerebral arteries	0.646	0.353	0.000
I27.8 Other specified pulmonary heart diseases	0.645	0.355	0.000
I08.3 Combined disorders of mitral, aortic and tricuspid valves	0.645	0.355	0.000
I63.5 Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries	0.644	0.355	0.000
I51 Complications and ill-defined descriptions of heart disease	0.641	0.359	0.000
C92.9 Myeloid leukaemia, unspecified	0.640	0.360	0.000
I13 Hypertensive heart and renal disease	0.635	0.365	0.000
C88 Malignant immunoproliferative diseases	0.630	0.370	0.000
I27.2 Other secondary pulmonary hypertension	0.629	0.371	0.000
C81 Hodgkin's disease	0.627	0.373	0.000
I51.7 Cardiomegaly	0.621	0.379	0.000
I69.8 Sequelae of other and unspecified cerebrovascular diseases	0.619	0.381	0.000
I24.1 Dressler's syndrome	0.619	0.381	0.000
I25.4 Coronary artery aneurysm	0.618	0.382	0.000
H65-H75 Diseases of middle ear and mastoid	0.611	0.389	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.610	0.389	0.000
C85.0 Lymphosarcoma	0.610	0.389	0.000
H65 Nonsuppurative otitis media	0.610	0.390	0.000
C83.3 Large cell (diffuse)	0.610	0.390	0.000
C93 Monocytic leukaemia	0.610	0.390	0.000
C95 Leukaemia of unspecified cell type	0.609	0.391	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.609	0.391	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.608	0.392	0.000
C94 Other leukaemias of specified cell type	0.608	0.392	0.000
C86 Other specified types of T/NK-cell lymphoma	0.608	0.392	0.000
I24.8 Other forms of acute ischaemic heart disease	0.604	0.396	0.000
C83.0 Small cell (diffuse)	0.598	0.402	0.000
I63.4 Cerebral infarction due to embolism of cerebral arteries	0.597	0.402	0.000
H40.2 Primary angle-closure glaucoma	0.597	0.403	0.000
C84.0 Mycosis fungoides	0.596	0.404	0.000
I28 Other diseases of pulmonary vessels	0.591	0.409	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.589	0.411	0.000
C92.7 Other myeloid leukaemia	0.589	0.411	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.589	0.411	0.000
C92.5 Acute myelomonocytic leukaemia	0.589	0.411	0.000
C92.3 Myeloid sarcoma	0.589	0.411	0.000
C92.2 Subacute myeloid leukaemia	0.589	0.411	0.000
I37 Pulmonary valve disorders	0.589	0.411	0.000
H71 Cholesteatoma of middle ear	0.588	0.412	0.000
H40-H42 Glaucoma	0.587	0.413	0.000
I27.9 Pulmonary heart disease, unspecified	0.586	0.414	0.000
I21 Acute myocardial infarction	0.583	0.417	0.000
I33 Acute and subacute endocarditis	0.582	0.418	0.000
I10 Essential (primary) hypertension	0.580	0.420	0.000
I66.8 Occlusion and stenosis of other cerebral artery	0.580	0.420	0.000
I66.3 Occlusion and stenosis of cerebellar arteries	0.580	0.420	0.000
I66.2 Occlusion and stenosis of posterior cerebral artery	0.580	0.420	0.000
I66.1 Occlusion and stenosis of anterior cerebral artery	0.580	0.420	0.000
C82.3 Follicular lymphoma grade IIIa	0.579	0.421	0.000
H65.3 Chronic mucoid otitis media	0.574	0.426	0.000
I09 Other rheumatic heart diseases	0.573	0.427	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.570	0.429	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.570	0.429	0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.570	0.429	0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.570	0.429	0.000
C84.3 Lymphoepithelioid lymphoma	0.570	0.429	0.000
C84.2 T-zone lymphoma	0.570	0.429	0.000
C84.1 Sezary's diease	0.570	0.429	0.000
Chapter VIII Diseases of the ear and mastoid process	0.569	0.431	0.000
I67 Other cerebrovascular diseases	0.568	0.432	0.000
H65.9 Nonsuppurative otitis media, unspecified	0.568	0.432	0.000
I65 Occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction	0.566	0.434	0.000
H40.8 Other glaucoma	0.562	0.438	0.000
H72 Perforation of tympanic membrane	0.562	0.438	0.000
H40.5 Glaucoma secondary to other eye disorders	0.560	0.440	0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.554	0.446	0.000
I61.3 Intracerebral haemorrhage in brain stem	0.551	0.448	0.000
C83.1 Small cleaved cell (diffuse)	0.551	0.449	0.000
I06 Rheumatic aortic valve diseases	0.551	0.449	0.000
I40 Acute myocarditis	0.549	0.451	0.000
C91 Lymphoid leukaemia	0.548	0.452	0.000
I44 Atrioventricular and left bundle-branch block	0.547	0.453	0.000
C92.1 Chronic myeloid leukaemia	0.547	0.453	0.000
H72.9 Perforation of tympanic membrane, unspecified	0.545	0.455	0.000
Chapter VII Diseases of the eye and adnexa	0.544	0.456	0.000
I51.6 Cardiovascular disease, unspecified	0.537	0.463	0.000
I51.3 Intracardiac thrombosis, not elsewhere classified	0.534	0.466	0.000
I00 Rheumatic fever without mention of heart involvement	0.533	0.467	0.000
H60-H62 Diseases of external ear	0.533	0.467	0.000
I37.1 Pulmonary valve insufficiency	0.531	0.469	0.000
# Top node	0.527	0.473	0.000
I44.2 Atrioventricular block, complete	0.527	0.473	0.000
H15-H22 Disorders of sclera, cornea, iris and ciliary body	0.526	0.474	0.000
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities	0.524	0.476	0.000
C83.6 Undifferentiated (diffuse)	0.524	0.476	0.000
C83.5 Lymphoblastic (diffuse)	0.524	0.476	0.000
C83.4 Immunoblastic (diffuse)	0.524	0.476	0.000
C83.2 Mixed small and large cell (diffuse)	0.524	0.476	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.521	0.478	0.000
I02 Rheumatic chorea	0.521	0.479	0.000
I01 Rheumatic fever with heart involvement	0.521	0.479	0.000
I08.9 Multiple valve disease, unspecified	0.520	0.480	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.518	0.482	0.000
I33.0 Acute and subacute infective endocarditis	0.518	0.482	0.000
I27.1 Kyphoscoliotic heart disease	0.516	0.484	0.000
I66.9 Occlusion and stenosis of unspecified cerebral artery	0.513	0.487	0.000
H65.4 Other chronic nonsuppurative otitis media	0.513	0.487	0.000
I68.8 Other cerebrovascular disorders in diseases classified elsewhere	0.512	0.487	0.000
I68.2 Cerebral arteritis in other diseases classified elsewhere	0.512	0.487	0.000
I68.1 Cerebral arteritis in infectious and parasitic diseases classified elsewhere	0.512	0.487	0.000
I68.0 Cerebral amyloid angiopathy	0.512	0.487	0.000
C83.7 Burkitt's tumour	0.512	0.488	0.000
I67.2 Cerebral atherosclerosis	0.511	0.489	0.000
I08.8 Other multiple valve diseases	0.510	0.489	0.000
I08.0 Disorders of both mitral and aortic valves	0.510	0.490	0.000
I07 Rheumatic tricuspid valve diseases	0.508	0.491	0.000
H70 Mastoiditis and related conditions	0.507	0.493	0.000
H61 Other disorders of external ear	0.506	0.494	0.000
Q20-Q28 Congenital malformations of the circulatory system	0.505	0.495	0.000
H65.2 Chronic serous otitis media	0.501	0.499	0.000
I45 Other conduction disorders	0.501	0.499	0.000
H40.4 Glaucoma secondary to eye inflammation	0.498	0.502	0.000
I23.6 Thrombosis of atrium, auricular appendage and ventricle as current complications following acute myocardial infarction	0.495	0.505	0.000
I23.5 Rupture of papillary muscle as current complication following acute myocardial infarction	0.495	0.505	0.000
I23.4 Rupture of chordae tendineae as current complication following acute myocardial infarction	0.495	0.505	0.000
I23.3 Rupture of cardiac wall without haemopericardium as current complication following acute myocardial infarction	0.495	0.505	0.000
I23.2 Ventricular septal defect as current complication following acute myocardial infarction	0.495	0.505	0.000
I23.1 Atrial septal defect as current complication following acute myocardial infarction	0.495	0.505	0.000
I23.0 Haemopericardium as current complication following acute myocardial infarction	0.495	0.505	0.000
I51.8 Other ill-defined heart diseases	0.489	0.511	0.000
H66 Suppurative and unspecified otitis media	0.488	0.512	0.000
H20 Iridocyclitis	0.487	0.513	0.000
I44.6 Other and unspecified fascicular block	0.486	0.514	0.000
C81.1 Nodular sclerosis	0.486	0.514	0.000
I61.4 Intracerebral haemorrhage in cerebellum	0.485	0.515	0.000
C82.6 Cutaneous follicle centre lymphoma	0.482	0.518	0.000
C82.5 Diffuse follicle centre lymphoma	0.482	0.518	0.000
C82.4 Follicular lymphoma grade IIIb	0.482	0.518	0.000
C82.2 Large cell, follicular	0.482	0.518	0.000
Q60-Q64 Congenital malformations of the urinary system	0.482	0.518	0.000
I52 Other heart disorders in diseases classified elsewhere	0.480	0.520	0.000
I48 Atrial fibrillation and flutter	0.480	0.520	0.000
I43 Cardiomyopathy in diseases classified elsewhere	0.480	0.520	0.000
I41 Myocarditis in diseases classified elsewhere	0.480	0.520	0.000
I39 Endocarditis and heart valve disorders in diseases classified elsewhere	0.480	0.520	0.000
I32 Pericarditis in diseases classified elsewhere	0.480	0.520	0.000
C90.1 Plasma cell leukaemia	0.479	0.521	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.477	0.523	0.000
H61.2 Impacted cerumen	0.473	0.527	0.000
I62 Other nontraumatic intracranial haemorrhage	0.471	0.528	0.000
H65.1 Other acute nonsuppurative otitis media	0.469	0.531	0.000
H46-H48 Disorders of optic nerve and visual pathways	0.468	0.532	0.000
I23.8 Other current complications following acute myocardial infarction	0.468	0.532	0.000
I45.9 Conduction disorder, unspecified	0.467	0.533	0.000
H40.6 Glaucoma secondary to drugs	0.464	0.535	0.000
Q24 Other congenital malformations of heart	0.464	0.536	0.000
C82.0 Small cleaved cell, follicular	0.463	0.537	0.000
I40.9 Acute myocarditis, unspecified	0.463	0.537	0.000
H16 Keratitis	0.460	0.540	0.000
I51.5 Myocardial degeneration	0.460	0.540	0.000
I51.2 Rupture of papillary muscle, not elsewhere classified	0.460	0.540	0.000
I15 Secondary hypertension	0.456	0.543	0.000
I13.9 Hypertensive heart and renal disease, unspecified	0.455	0.545	0.000
I13.2 Hypertensive heart and renal disease with both (congestive) heart failure and renal failure	0.455	0.545	0.000
I13.1 Hypertensive heart and renal disease with renal failure	0.455	0.545	0.000
I13.0 Hypertensive heart and renal disease with (congestive) heart failure	0.455	0.545	0.000
H40.3 Glaucoma secondary to eye trauma	0.455	0.545	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.455	0.545	0.000
I21.9 Acute myocardial infarction, unspecified	0.453	0.547	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.451	0.548	0.000
C88.7 Other malignant immunoproliferative diseases	0.451	0.548	0.000
C88.3 Immunoproliferative small intestinal disease	0.451	0.548	0.000
C88.2 Gamma heavy chain disease	0.451	0.548	0.000
C88.1 Alpha heavy chain disease	0.451	0.548	0.000
I21.4 Acute subendocardial myocardial infarction	0.451	0.549	0.000
Chapter V Mental and behavioural disorders	0.451	0.549	0.000
C81.7 Other Hodgkin's disease	0.449	0.551	0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.449	0.551	0.000
C81.3 Lymphocytic depletion	0.449	0.551	0.000
C81.2 Mixed cellularity	0.449	0.551	0.000
C81.9 Hodgkin's disease, unspecified	0.449	0.551	0.000
H20.8 Other iridocyclitis	0.449	0.551	0.000
Chapter II Neoplasms	0.448	0.552	0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.447	0.552	0.000
I28.8 Other specified diseases of pulmonary vessels	0.446	0.554	0.000
I21.3 Acute transmural myocardial infarction of unspecified site	0.444	0.556	0.000
C91.9 Lymphoid leukaemia, unspecified	0.443	0.557	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.442	0.558	0.000
I45.2 Bifascicular block	0.441	0.559	0.000
H61.8 Other specified disorders of external ear	0.440	0.560	0.000
Q25 Congenital malformations of great arteries	0.439	0.561	0.000
C93.1 Chronic monocytic leukaemia	0.439	0.561	0.000
H75 Other disorders of middle ear and mastoid in diseases classified elsewhere	0.438	0.562	0.000
H68 Eustachian salpingitis and obstruction	0.438	0.562	0.000
H67 Otitis media in diseases classified elsewhere	0.438	0.562	0.000
C95.9 Leukaemia, unspecified	0.438	0.562	0.000
C93.9 Monocytic leukaemia, unspecified	0.437	0.563	0.000
C93.7 Other monocytic leukaemia	0.437	0.563	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.437	0.563	0.000
C93.2 Subacute monocytic leukaemia	0.437	0.563	0.000
C93.0 Acute monocytic leukaemia	0.437	0.563	0.000
C95.7 Other leukaemia of unspecified cell type	0.437	0.563	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.437	0.563	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.437	0.563	0.000
C95.0 Acute leukaemia of unspecified cell type	0.437	0.563	0.000
Q38-Q45 Other congenital malformations of the digestive system	0.437	0.563	0.000
C90.3 Solitary plasmacytoma	0.436	0.563	0.000
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.436	0.564	0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.436	0.564	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.436	0.564	0.000
C86.4 Blastic NK-cell lymphoma	0.436	0.564	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.436	0.564	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.436	0.564	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.436	0.564	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.436	0.564	0.000
C94.7 Other specified leukaemias	0.436	0.564	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.436	0.564	0.000
C94.5 Acute myelofibrosis	0.436	0.564	0.000
C94.4 Acute panmyelosis	0.436	0.564	0.000
C94.3 Mast cell leukaemia	0.436	0.564	0.000
C94.2 Acute megakaryoblastic leukaemia	0.436	0.564	0.000
C94.1 Chronic erythraemia	0.436	0.564	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.436	0.564	0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.436	0.564	0.000
C96.8 Histiocytic sarcoma	0.436	0.564	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.436	0.564	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.436	0.564	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.436	0.564	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.436	0.564	0.000
C96.3 True histiocytic lymphoma	0.436	0.564	0.000
C96.2 Malignant mast cell tumour	0.436	0.564	0.000
C96.1 Malignant histiocytosis	0.436	0.564	0.000
C96.0 Letterer-Siwe disease	0.436	0.564	0.000
I65.3 Occlusion and stenosis of multiple and bilateral precerebral arteries	0.434	0.566	0.000
I09.9 Rheumatic heart disease, unspecified	0.433	0.566	0.000
Q61 Cystic kidney disease	0.432	0.568	0.000
I51.4 Myocarditis, unspecified	0.430	0.570	0.000
I51.1 Rupture of chordae tendineae, not elsewhere classified	0.430	0.570	0.000
I21.1 Acute transmural myocardial infarction of inferior wall	0.429	0.571	0.000
H72.2 Other marginal perforations of tympanic membrane	0.429	0.571	0.000
I08.1 Disorders of both mitral and tricuspid valves	0.428	0.572	0.000
H43-H45 Disorders of vitreous body and globe	0.427	0.573	0.000
C81.0 Lymphocytic predominance	0.427	0.573	0.000
H15 Disorders of sclera	0.427	0.573	0.000
Q50-Q56 Congenital malformations of genital organs	0.424	0.576	0.000
F40-F48 Neurotic, stress-related and somatoform disorders	0.424	0.576	0.000
I28.9 Disease of pulmonary vessels, unspecified	0.424	0.576	0.000
I28.1 Aneurysm of pulmonary artery	0.424	0.576	0.000
I28.0 Arteriovenous fistula of pulmonary vessels	0.424	0.576	0.000
H70.1 Chronic mastoiditis	0.423	0.577	0.000
Q60 Renal agenesis and other reduction defects of kidney	0.423	0.577	0.000
I37.9 Pulmonary valve disorder, unspecified	0.422	0.578	0.000
I37.8 Other pulmonary valve disorders	0.422	0.578	0.000
I37.2 Pulmonary valve stenosis with insufficiency	0.422	0.578	0.000
I37.0 Pulmonary valve stenosis	0.422	0.578	0.000
H65.0 Acute serous otitis media	0.422	0.578	0.000
H42 Glaucoma in diseases classified elsewhere	0.421	0.579	0.000
I33.9 Acute endocarditis, unspecified	0.421	0.579	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.421	0.579	0.000
I67.1 Cerebral aneurysm, nonruptured	0.420	0.580	0.000
F40 Phobic anxiety disorders	0.419	0.581	0.000
H47 Other disorders of optic [2nd] nerve and visual pathways	0.418	0.582	0.000
C90.0 Multiple myeloma	0.418	0.582	0.000
I21.X Presumed acute myicardial infaction (unconfirmed)	0.418	0.582	0.000
Q21 Congenital malformations of cardiac septa	0.417	0.583	0.000
C91.4 Hairy-cell leukaemia	0.416	0.584	0.000
H22 Disorders of iris and ciliary body in diseases classified elsewhere	0.416	0.584	0.000
F40.2 Specific (isolated) phobias	0.415	0.585	0.000
I44.4 Left anterior fascicular block	0.415	0.585	0.000
H40.9 Glaucoma, unspecified	0.414	0.586	0.000
F80-F89 Disorders of psychological development	0.412	0.588	0.000
Q10-Q18 Congenital malformations of eye, ear, face and neck	0.412	0.588	0.000
I09.8 Other specified rheumatic heart diseases	0.411	0.589	0.000
I09.2 Chronic rheumatic pericarditis	0.411	0.589	0.000
I09.1 Rheumatic diseases of endocardium, valve unspecified	0.411	0.589	0.000
I09.0 Rheumatic myocarditis	0.411	0.589	0.000
C69 Malignant neoplasm of eye and adnexa	0.409	0.591	0.000
H10-H13 Disorders of conjunctiva	0.408	0.592	0.000
I67.7 Cerebral arteritis, not elsewhere classified	0.407	0.592	0.000
I67.6 Nonpyogenic thrombosis of intracranial venous system	0.407	0.592	0.000
I67.5 Moyamoya disease	0.407	0.592	0.000
I67.4 Hypertensive encephalopathy	0.407	0.592	0.000
I67.3 Progressive vascular leukoencephalopathy	0.407	0.592	0.000
I65.9 Occlusion and stenosis of unspecified precerebral artery	0.406	0.594	0.000
I65.8 Occlusion and stenosis of other precerebral artery	0.406	0.594	0.000
I65.1 Occlusion and stenosis of basilar artery	0.406	0.594	0.000
C91.0 Acute lymphoblastic leukaemia	0.405	0.595	0.000
C90.2 Plasmacytoma, extramedullary	0.404	0.596	0.000
I22 Subsequent myocardial infarction	0.404	0.596	0.000
H16.0 Corneal ulcer	0.403	0.597	0.000
Q51 Congenital malformations of uterus and cervix	0.402	0.598	0.000
H55-H59 Other disorders of eye and adnexa	0.402	0.598	0.000
I21.2 Acute transmural myocardial infarction of other sites	0.401	0.599	0.000
H61.1 Non-infective disorders of pinna	0.400	0.600	0.000
Q24.8 Other specified congenital malformations of heart	0.399	0.601	0.000
F10-F19 Mental and behavioural disorders due to psychoactive substance use	0.395	0.605	0.000
I06.9 Rheumatic aortic valve disease, unspecified	0.395	0.605	0.000
I06.8 Other rheumatic aortic valve diseases	0.395	0.605	0.000
I06.2 Rheumatic aortic stenosis with insufficiency	0.395	0.605	0.000
I06.1 Rheumatic aortic insufficiency	0.395	0.605	0.000
I06.0 Rheumatic aortic stenosis	0.395	0.605	0.000
H72.1 Attic perforation of tympanic membrane	0.394	0.606	0.000
I40.8 Other acute myocarditis	0.394	0.606	0.000
I40.1 Isolated myocarditis	0.394	0.606	0.000
I40.0 Infective myocarditis	0.394	0.606	0.000
I36 Nonrheumatic tricuspid valve disorders	0.393	0.606	0.000
I67.0 Dissection of cerebral arteries, nonruptured	0.393	0.606	0.000
H40.0 Glaucoma suspect	0.393	0.607	0.000
C91.8 Mature B-cell leukaemia Burkitt-type	0.393	0.607	0.000
C91.7 Other lymphoid leukaemia	0.393	0.607	0.000
C91.6 Prolymphocytic leukaemia of T-cell type	0.393	0.607	0.000
C91.5 Adult T-cell leukaemia	0.393	0.607	0.000
C91.3 Prolymphocytic leukaemia	0.393	0.607	0.000
C91.2 Subacute lymphocytic leukaemia	0.393	0.607	0.000
I44.5 Left posterior fascicular block	0.392	0.608	0.000
H60 Otitis externa	0.392	0.608	0.000
Q24.9 Congenital malformation of the heart, unspecified	0.391	0.609	0.000
H66.4 Suppurative otitis media, unspecified	0.390	0.610	0.000
H74 Other disorders of middle ear and mastoid	0.389	0.611	0.000
Q61.2 Polycystic kidney, adult type	0.389	0.611	0.000
I44.0 Atrioventricular block, first degree	0.389	0.611	0.000
I63.3 Cerebral infarction due to thrombosis of cerebral arteries	0.388	0.612	0.001
I45.4 Nonspecific intraventricular block	0.387	0.612	0.000
H66.1 Chronic tubotympanic suppurative otitis media	0.386	0.614	0.000
I20.0 Unstable angina	0.386	0.614	0.000
C71 Malignant neoplasm of brain	0.386	0.614	0.000
H20.0 Acute and subacute iridocyclitis	0.384	0.615	0.000
F60-F69 Disorders of adult personality and behaviour	0.384	0.616	0.000
D37-D48 Neoplasms of uncertain or unknown behaviour	0.384	0.616	0.000
H20.9 Iridocyclitis, unspecified	0.383	0.617	0.000
Q62 Congenital obstructive defects of renal pelvis and congenital malformations of ureter	0.383	0.617	0.000
H62 Disorders of external ear in diseases classified elsewhere	0.382	0.618	0.000
Q28 Other congenital malformations of circulatory system	0.382	0.618	0.000
I45.3 Trifascicular block	0.381	0.619	0.000
H70.9 Mastoiditis, unspecified	0.380	0.620	0.000
I65.0 Occlusion and stenosis of vertebral artery	0.379	0.620	0.000
H47.0 Disorders of optic nerve, not elsewhere classified	0.378	0.622	0.000
Chapter XVI Certain conditions originating in the perinatal period	0.378	0.622	0.000
H66.2 Chronic atticoantral suppurative otitis media	0.376	0.624	0.000
Q35-Q37 Cleft lip and cleft palate	0.376	0.624	0.000
Q30-Q34 Congenital malformations of the respiratory system	0.376	0.624	0.000
I05 Rheumatic mitral valve diseases	0.375	0.625	0.000
Q51.3 Bicornate uterus	0.375	0.625	0.000
Q43 Other congenital malformations of intestine	0.375	0.625	0.000
I01.9 Acute rheumatic heart disease, unspecified	0.373	0.626	0.000
I01.8 Other acute rheumatic heart disease	0.373	0.626	0.000
I01.2 Acute rheumatic myocarditis	0.373	0.626	0.000
I01.1 Acute rheumatic endocarditis	0.373	0.626	0.000
I01.0 Acute rheumatic pericarditis	0.373	0.626	0.000
I02.9 Rheumatic chorea without heart involvement	0.373	0.626	0.000
I02.0 Rheumatic chorea with heart involvement	0.373	0.626	0.000
Q60.0 Renal agenesis, unilateral	0.373	0.627	0.000
H61.9 Disorder of external ear, unspecified	0.372	0.628	0.000
Q61.0 Congenital single renal cyst	0.372	0.628	0.000
H17 Corneal scars and opacities	0.370	0.630	0.000
H66.9 Otitis media, unspecified	0.369	0.631	0.000
H72.8 Other perforations of tympanic membrane	0.369	0.631	0.000
Q00-Q07 Congenital malformations of the nervous system	0.369	0.631	0.000
Q65-Q79 Congenital malformations and deformations of the musculoskeletal system	0.369	0.631	0.000
I08.2 Disorders of both aortic and tricuspid valves	0.368	0.631	0.000
D43 Neoplasm of uncertain or unknown behaviour of brain and central nervous system	0.368	0.632	0.000
H00-H06 Disorders of eyelid, lacrimal system and orbit	0.368	0.632	0.000
Q90-Q99 Chromosomal abnormalities, not elsewhere classified	0.367	0.633	0.000
F80 Specific developmental disorders of speech and language	0.367	0.633	0.000
F12 Mental and behavioural disorders due to use of cannabinoids	0.365	0.635	0.000
I07.9 Tricuspid valve disease, unspecified	0.365	0.635	0.000
I07.8 Other tricuspid valve diseases	0.365	0.635	0.000
I07.2 Tricuspid stenosis with insufficiency	0.365	0.635	0.000
I07.0 Tricuspid stenosis	0.365	0.635	0.000
H19 Disorders of sclera and cornea in diseases classified elsewhere	0.364	0.636	0.000
H70.8 Other mastoiditis and related conditions	0.364	0.636	0.000
H70.2 Petrositis	0.364	0.636	0.000
H70.0 Acute mastoiditis	0.364	0.636	0.000
Q25.3 Stenosis of aorta	0.363	0.636	0.000
H10 Conjunctivitis	0.364	0.636	0.000
Q25.4 Other congenital malformations of aorta	0.363	0.637	0.000
H47.2 Optic atrophy	0.363	0.637	0.000
Q26 Congenital malformations of great veins	0.362	0.638	0.000
Q22 Congenital malformations of pulmonary and tricuspid valves	0.362	0.638	0.000
Q20 Congenital malformations of cardiac chambers and connexions	0.362	0.638	0.000
C69.3 Choroid	0.361	0.639	0.000
Q24.5 Malformation of coronary vessels	0.361	0.639	0.000
H43 Disorders of vitreous body	0.360	0.640	0.000
F11 Mental and behavioural disorders due to use of opioids	0.360	0.640	0.000
Q21.9 Congenital malformation of cardiac septum, unspecified	0.359	0.641	0.000
I45.0 Right fascicular block	0.359	0.641	0.000
H69 Other disorders of Eustachian tube	0.358	0.642	0.000
I35 Nonrheumatic aortic valve disorders	0.358	0.642	0.000
H16.9 Keratitis, unspecified	0.355	0.645	0.000
C97-C97 Malignant neoplasms of independent (primary) multiple sites	0.354	0.646	0.000
H15.0 Scleritis	0.353	0.647	0.000
H21 Other disorders of iris and ciliary body	0.350	0.650	0.000
H66.0 Acute suppurative otitis media	0.350	0.650	0.000
H20.2 Lens-induced iridocyclitis	0.349	0.651	0.000
I51.0 Cardiac septal defect, acquired	0.348	0.652	0.000
I38 Endocarditis, valve unspecified	0.348	0.652	0.000
I45.6 Preexcitation syndrome	0.348	0.652	0.000
H43.8 Other disorders of vitreous body	0.347	0.653	0.000
I51.9 Heart disease, unspecified	0.345	0.655	0.000
H16.1 Other superficial keratitis without conjunctivitis	0.345	0.655	0.000
H01 Other inflammation of eyelid	0.345	0.655	0.000
I32.8 Pericarditis in other diseases classified elsewhere	0.344	0.655	0.000
I32.1 Pericarditis in other infectious and parasitic diseases classified elsewhere	0.344	0.655	0.000
I32.0 Pericarditis in bacterial diseases classified elsewhere	0.344	0.655	0.000
I39.8 Endocarditis, valve unspecified, in diseases classified elsewhere	0.344	0.655	0.000
I39.4 Multiple valve disorders in diseases classified elsewhere	0.344	0.655	0.000
I39.3 Pulmonary valve disorders in diseases classified elsewhere	0.344	0.655	0.000
I39.2 Tricuspid valve disorders in diseases classified elsewhere	0.344	0.655	0.000
I39.1 Aortic valve disorders in diseases classified elsewhere	0.344	0.655	0.000
I39.0 Mitral valve disorders in diseases classified elsewhere	0.344	0.655	0.000
I41.8 Myocarditis in other diseases classified elsewhere	0.344	0.655	0.000
I41.2 Myocarditis in other infectious and parasitic diseases classified elsewhere	0.344	0.655	0.000
I41.1 Myocarditis in viral diseases classified elsewhere	0.344	0.655	0.000
I41.0 Myocarditis in bacterial diseases classified elsewhere	0.344	0.655	0.000
I43.8 Cardiomyopathy in other diseases classified elsewhere	0.344	0.655	0.000
I43.2 Cardiomyopathy in nutritional diseases	0.344	0.655	0.000
I43.1 Cardiomyopathy in metabolic diseases	0.344	0.655	0.000
I43.0 Cardiomyopathy in infectious and parasitic diseases classified elsewhere	0.344	0.655	0.000
I48.9 Atrial fibrillation and atrial flutter, unspecified	0.344	0.655	0.000
I48.4 Atypical atrial flutter	0.344	0.655	0.000
I48.3 Typical atrial flutter	0.344	0.655	0.000
I48.2 Chronic atrial fibrillation	0.344	0.655	0.000
I48.1 Persistent atrial fibrillation	0.344	0.655	0.000
I48.0 Paroxysmal atrial fibrillation	0.344	0.655	0.000
I52.8 Other heart disorders in other diseases classified elsewhere	0.344	0.655	0.000
I52.1 Other heart disorders in other infectious and parasitic diseases classified elsewhere	0.344	0.655	0.000
I52.0 Other heart disorders in bacterial diseases classified elsewhere	0.344	0.655	0.000
F81 Specific developmental disorders of scholastic skills	0.344	0.656	0.000
Q45 Other congenital malformations of digestive system	0.343	0.657	0.000
H18 Other disorders of cornea	0.341	0.659	0.000
H57 Other disorders of eye and adnexa	0.340	0.660	0.000
F12.1 Harmful use	0.339	0.661	0.000
Q23 Congenital malformations of aortic and mitral valves	0.338	0.661	0.000
I62.1 Nontraumatic extradural haemorrhage	0.338	0.662	0.000
H22.1 Iridocyclitis in other diseases classified elsewhere	0.338	0.662	0.000
I46 Cardiac arrest	0.336	0.664	0.000
H48 Disorders of optic [2nd] nerve and visual pathways in diseases classified elsewhere	0.336	0.664	0.000
D43.2 Brain, unspecified	0.336	0.664	0.000
Q43.8 Other specified congenital malformations of intestine	0.334	0.666	0.000
F80.1 Expressive language disorder	0.334	0.666	0.000
Q51.8 Other congenital malformations of uterus and cervix	0.334	0.666	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations